Partnering with Pharmacists Reduces Readmission Rates for Patients on High-Risk Meds

This retrospective study from Mayo Clinic shows that enhancing the relationship between patients and pharmacists could significantly lower readmission rates by up to 50% for patients taking at least one high-risk medication. The three-year study at tertiary care center reviewed outcomes among patients who did or did not have aRead …

Read morePartnering with Pharmacists Reduces Readmission Rates for Patients on High-Risk Meds

Put the Script Pad Down: FDA’s New Drug Approvals Pose Significant Risks

patient compliance

For every 100 new drugs introduced in the market, there have been 34 withdrawals or new black box warnings in the past 25 years. Since 1992, FDA sped up the pace and approval process for pharmaceutical companies willing to pay a fee. Approval time was cut in half, but with it came a significant number of safety withdrawals and warnings. This study, released today in Health Affairs, shows the expeditious process has placed millions of Americans at risk, essentially making them unwitting members of safety trials after the drug was approved.

Hidden Disruptions In Metabolic Syndrome: Drug-Induced Nutrient Depletion As A Pathway To Accelerated Pathophysiology Of Metabolic Syndrome

James B. LaValle, RPh, MS, ND, CCN One of the potential challenges facing healthcare professionals today is the problem of drug- induced disease. With polypharmacy prescribing occurring in younger and younger populations, it is becoming increasingly important to assess nutrient depletion risks as they relate to future symptoms, conditions, or progression

Read moreHidden Disruptions In Metabolic Syndrome: Drug-Induced Nutrient Depletion As A Pathway To Accelerated Pathophysiology Of Metabolic Syndrome